Gene · 923
Papers1,942
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,942
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endogenous and viral microRNAs in nasal secretions of water buffaloes (Bubalus bubalis) after Bubaline alphaherpesvirus 1 (BuHV-1) challenge infection. | Vet Res | 2023 | 37277883 | PubTator, text mining | PubMed |
| Genome-wide search identified DNA methylation sites that regulate the metabolome. | Front Genet | 2023 | 37274792 | PubTator, text mining | PubMed |
| Multi-omics in Crohn's disease: New insights from inside. | Comput Struct Biotechnol J | 2023 | 37273853 | PubTator, text mining | PubMed |
| Getting the chronological age out of DNA: using insights of age-dependent DNA methylation for forensic DNA applications. | Genes Genomics | 2023 | 37253906 | PubTator, text mining | PubMed |
| Immunological Profile of Vasospasm after Subarachnoid Hemorrhage. | Int J Mol Sci | 2023 | 37240207 | PubTator, text mining | PubMed |
| Immunotherapy of hepatocellular carcinoma: recent progress and new strategy. | Front Immunol | 2023 | 37234162 | PubTator, text mining | PubMed |
| A publication-wide association study (PWAS), historical language models to prioritise novel therapeutic drug targets. | Sci Rep | 2023 | 37225853 | PubTator, text mining | PubMed |
| The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint era. | Cancer Immunol Immunother | 2023 | 37217603 | PubTator, text mining | PubMed |
| Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer. | Comput Struct Biotechnol J | 2023 | 37216014 | PubTator, text mining | PubMed |
Identification and validation of a novel signature based on cell-cell communication in head and neck squamous cell carcinoma by integrated analysis of single-cell transcriptome and bulk RNA-sequencing. | Front Oncol | 2023 | 37213285 | PubTator, text mining | PubMed |
| Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target. | Biomedicines | 2023 | 37189651 | PubTator, text mining | PubMed |
| Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion Diagnostics. | Diagnostics (Basel) | 2023 | 37189577 | PubTator, text mining | PubMed |
| NMR-Based Metabolomics to Analyze the Effects of a Series of Monoamine Oxidases-B Inhibitors on U251 Cells. | Biomolecules | 2023 | 37189348 | PubTator, text mining | PubMed |
| Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers. | Front Endocrinol (Lausanne) | 2023 | 37181043 | PubTator, text mining | PubMed |
| Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus. | BioDrugs | 2023 | 37178431 | PubTator, text mining | PubMed |
| Targeted Therapy for SLE-What Works, What Doesn't, What's Next. | J Clin Med | 2023 | 37176637 | PubTator, text mining | PubMed |
| Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis. | Cells | 2023 | 37174646 | PubTator, text mining | PubMed |
| Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. | Cancers (Basel) | 2023 | 37174089 | PubTator, text mining | PubMed |
| Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond. | Pharmaceut Med | 2023 | 37115494 | PubTator, text mining | PubMed |
| Severe Asthmatic Responses: The Impact of TSLP. | Int J Mol Sci | 2023 | 37108740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/923/papers?page=13